Press & Media
In the news
Brian Pedlar has led public medical-technology companies for more than two decades, and his work has been covered by industry and financial press throughout.
Below is a selection of that coverage, followed by the full record of Covalon Technologies (TSXV: COV) news releases from his tenure as CEO (2010–September 2023).
Selected coverage
Independent editorial and marquee announcements from Brian's tenure. Links open on the original publisher.
Pedlar leaves Merge/Cedara
AuntMinnie · 2006-08-20
Trade coverage of his departure as interim co-CEO of Merge and president of Cedara Software.
Covalon Technologies news releases (2010–2023)
The full chronological run of Covalon (TSXV: COV) news releases during Brian Pedlar's tenure as CEO.
2010
2011
2012
- Covalon to Feature its Advanced Wound Care and Medical Coating Products at Arab Health Congress in Dubai CNW · Jan 20, 2012
- Covalon Provides Corporate Update and Year End Financial Results CNW · Jan 27, 2012
- Covalon Provides Corporate Update and First Quarter Fiscal 2012 Financial Results CNW · Mar 30, 2012
- Covalon Annual Shareholders Meeting To Be Held Thursday May 10th, 2012 CNW · Apr 4, 2012
- Covalon to Feature New Advanced Wound Care Products at the Symposium on Advanced Wound Care in Atlanta CNW · Apr 19, 2012
- Covalon to Showcase Innovative Products for Infusion Care at the 2012 Infusion Nurses Society Annual Convention CNW · Apr 30, 2012
- Covalon Announces Major Milestone: Achieves FDA Approval for IV Clear CNW · May 15, 2012
- Covalon to Unveil its SilverCoat Antimicrobial Silicone Foley Catheter at 2012 AUA Meeting CNW · May 18, 2012
- Covalon Provides Corporate Update and Second Quarter Fiscal 2012 Financial Results CNW · May 28, 2012
- Covalon Presents Its Latest Antimicrobial Products at APIC CNW · Jun 4, 2012
- Covalon to Present FDA Cleared IV Clear Antimicrobial Silicone Adhesive Dressing at FIME CNW · Aug 8, 2012
- Covalon Announces FDA Clearance for SurgiClear Antimicrobial Silicone Wound Dressing CNW · Aug 21, 2012
- Covalon Provides Corporate Update and Third Quarter Fiscal 2012 Financial Results CNW · Aug 28, 2012
- Covalon Announces Closing of Non-Brokered Private Placement CNW · Oct 26, 2012
- Covalon Announces New Chairman and CFO CNW · Dec 6, 2012
2013
- Covalon Announces Departure of CFO CNW · Jan 9, 2013
- Covalon Announces Year End Financial Results and Resignation of Director CNW · Jan 28, 2013
- Covalon Announces First Quarter Financial Results CNW · Mar 1, 2013
- Covalon Proposes Share Consolidation CNW · May 16, 2013
- Covalon Announces Second Quarter Financial Results CNW · May 30, 2013
- Covalon Announces Results of Annual and Special Meeting of Shareholders CNW · Jun 14, 2013
- Covalon Announces Share Consolidation CNW · Jul 15, 2013
- Covalon Announces Third Quarter Financial Results CNW · Aug 7, 2013
- Covalon Announces Non-Brokered Private Placement With Insiders Participating CNW · Aug 16, 2013
- Covalon Announces Closing of Non-Brokered Private Placement CNW · Aug 30, 2013
- Covalon Receives Final TSXV Approval for Private Placement and Announces Issuance of Stock Options CNW · Sep 27, 2013
- Covalon Announces Major License and Distribution Agreement with Mölnlycke Health Care CNW · Nov 4, 2013
- Covalon To Showcase New Wound Healing and Infection Management Products at MEDICA CNW · Nov 19, 2013
2014
2015
2016
- Covalon Chairman acquires additional shares and warrants CNW · Jan 11, 2016
- Covalon Presenting Its Latest Advanced Wound Care and Infection Control Products at Arab Health 2016 CNW · Jan 21, 2016
- Covalon Announces Annual Financial Results CNW · Jan 27, 2016
- Covalon Licenses IP to Prevent Ventilator-Associated Pneumonia from the University of Michigan CNW · Feb 9, 2016
- Covalon Announces Strong First Quarter Financial Results CNW · Feb 29, 2016
- Covalon First Quarter, 2016 Earnings Conference Call CNW · Mar 1, 2016
- Covalon Announces Issuance of Stock Options CNW · Mar 7, 2016
- Covalon to Present SurgiClear at AORN Surgical Conference and Expo CNW · Apr 1, 2016
- Covalon Signs Distribution Agreements and Commences Sales in Nine Countries across Latin America Business Wire (via Investing News) · May 19, 2016
- Covalon CEO Acquires Shares IR (ir.covalon.com) · Jun 2, 2016
- Covalon Signs Distribution Agreement with Medline MPO · Jun 16, 2016
- Covalon Wins $7.6M Twelve-Month Contract to Supply ColActive Plus to Saudi Arabia Covalon IR · Aug 3, 2016
- Covalon Wins $3.5M Supply Contract For Clear Vascular Access Dressings MPO · Aug 11, 2016
- Covalon CEO Provides Update on Anticipated Fiscal 2017 Financial Growth IR (legacy) · date uncertain
2017
2018
2019
2020
- Covalon Announces Breakthrough Antimicrobial Technology Formulated to Kill the COVID-19 Virus Covalon IR · Mar 31, 2020
- Covalon Delays Filing of Interim Financial Statements Due to COVID-19 and Provides Business Update CNW · May 29, 2020
- Covalon Granted Key Antimicrobial Patents in the United States, Canada, and Europe CNW · Jun 3, 2020
- Covalon Provides Business Update CNW · Jun 30, 2020
- Covalon Announces Conference Call to Discuss Third Quarter Financial Results CNW · Aug 21, 2020
- Covalon Announces Third Quarter Fiscal 2020 Results CNW · Aug 24, 2020
- Covalon Initiates Strategic Review to Enhance Shareholder Value CNW · Oct 21, 2020
- Covalon Announces Appointment of Amir Boloor as Board Chair and Fiscal 2019 AGM Voting Results CNW · Nov 13, 2020
- Covalon Announces First Quarter Fiscal 2020 Results IR (Q4 CDN PDF) · ~Mar 2020
2021
- Covalon Announces Fiscal 2020 Year-End Results CNW · Jan 28, 2021
- Covalon Announces Conference Call to Discuss First Quarter Financial Results CNW · Feb 26, 2021
- Covalon Announces First Quarter Fiscal 2021 Results CNW · Mar 1, 2021
- Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2021 Financial Results CNW · May 27, 2021
- Covalon Announces Fiscal 2021 Q2 Results CNW · May 31, 2021
- Covalon Announces Voting Results from Fiscal 2020 AGM CNW · Jul 2, 2021
- Covalon Announces Sale of its AquaGuard Product Line for US$30M (~CDN$38M) CNW · Jul 29, 2021
- Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2021 Financial Results CNW · Aug 26, 2021
- Covalon Announces Fiscal 2021 Q3 Results CNW · Aug 30, 2021
- Covalon Announces Retirement of Board Member CNW · Sep 24, 2021
- Covalon Announces Conference Call to Discuss Q4 and Year End Fiscal 2021 Financial Results CNW · Dec 8, 2021
- Covalon Announces Strong Year End and Fourth Quarter Results for Fiscal 2021 CNW · Dec 13, 2021
- Covalon Announces CFO Transition CNW · Dec 24, 2021
2022
- Covalon Announces Appointment of Interim CFO CNW · Jan 14, 2022
- Covalon Announces Conference Call to Discuss First Quarter Fiscal 2022 Financial Results CNW · Feb 16, 2022
- Covalon Announces First Quarter Fiscal 2022 Results CNW · Mar 1, 2022
- Covalon Announces Changes to its Board of Directors CNW · Mar 10, 2022
- Covalon Announces Voting Results from Fiscal 2021 AGM CNW · Mar 10, 2022
- Covalon Announces Issuance of Stock Options CNW · Mar 29, 2022
- Covalon Announces New Senior Vice President of Marketing CNW · Apr 26, 2022
- Covalon Attracts Well-Known Medical Industry Sales Executive CNW · May 19, 2022
- Covalon Technologies Ltd. Announces Normal Course Issuer Bid CNW · May 25, 2022
- Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2022 Financial Results CNW · May 26, 2022
- Covalon Announces Second Quarter Fiscal 2022 Results CNW · May 30, 2022
- Covalon Enters into Automatic Share Purchase Plan CNW · Jun 30, 2022
- Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2022 Financial Results CNW · Aug 24, 2022
- Covalon Announces Third Quarter Fiscal 2022 Results CNW · Aug 29, 2022
- Covalon Announces Issuance of Stock Options CNW · Sep 7, 2022
- Covalon Announces Expansion of its United States Pediatric Hospital Customer Base CNW · Sep 8, 2022
- Covalon to Introduce New Infection Prevention Products at the APHON Conference CNW · Sep 13, 2022
- Covalon's Dual Antimicrobial Surgical Site Dressing Adopted by Leading US Pediatric Hospital's Congenital Heart Program CNW · Sep 20, 2022
- Covalon to Showcase Infection Prevention Solutions at the Association for Vascular Access Annual Scientific Meeting CNW · Sep 26, 2022
- Covalon to Participate in the 12th International Pediatric Intestinal Failure and Rehabilitation Symposium in Toronto CNW · Sep 28, 2022
- Covalon to Participate in the ANCC Magnet Conference in Philadelphia CNW · Oct 11, 2022
- Closing Chronic Wounds with Collagen Powder: University of Michigan case study on ColActive Plus Powder CNW · Nov 1, 2022
- Covalon Launches New "CLABSI Conscious" Campaign to Help Children Heal Without Infections CNW · Nov 8, 2022
- Covalon's SurgiClear Dressing Plays an Important Part in Preventing Surgical Wound Infections at Top Children's Hospital CNW · Nov 21, 2022
2023
- Covalon Announces Conference Call to Discuss Q4 and Year End Fiscal 2022 Financial Results CNW · Jan 23, 2023
- Covalon Announces Q4 and Year End Results for Fiscal 2022 and Highlights Company Transformation CNW · Jan 25, 2023
- Covalon Announces Conference Call to Discuss First Quarter Fiscal 2023 Financial Results CNW · Feb 17, 2023
- Covalon to Participate for the First Time in NEO — The Conference for Neonatology (Las Vegas) CNW · Feb 20, 2023
- Covalon Announces Improved First Quarter Fiscal 2023 Results CNW · Feb 23, 2023
- Covalon To Hold Annual and Special Meeting of Shareholders on March 8, 2023 CNW · Feb 28, 2023
- Covalon Welcomes Martin Goldfarb, O.C., to its Board of Directors CNW · Mar 9, 2023
- Covalon Announces Voting Results from Fiscal 2022 AGM CNW · Mar 9, 2023
- Covalon to Participate in the Synova NICU Leadership Forum 2023 (Tucson) CNW · Mar 20, 2023
- Covalon Presents New CLABSI Conscious Series Webinar CNW · Mar 27, 2023
- Covalon Participating in the CVAA / World Congress on Vascular Access Joint Conference (Toronto) CNW · Apr 26, 2023
- Covalon Announces Second Quarter Results for Fiscal 2023 Covalon IR · May 25, 2023
- Covalon's IV Clear Dressing Recommended by Physicians at a Top-10 US Children's Hospital Covalon IR · Jun 13, 2023
- Covalon Announces Third Quarter Fiscal 2023 Results Covalon IR · Aug 16, 2023
Full archive compiled from public news-wire records (CNW Group / Cision, Business Wire, PR Newswire) and Covalon investor relations. Releases after September 2023 fall outside Brian's CEO tenure and are not listed.
